Beggars can't be choosers: how Imran Khan sold pakistani citizens to chinese laboratory

Beggars can't be choosers: how Imran Khan sold pakistani citizens to chinese laboratory

A letter dated April 21, 2020, received the desk of Major General Aamir Ikram, executive of the National Institute of Health (NIH), a 40-year-old vaccine research and manufacturing facility located in Chak Shezad in Islamabad. The letter was signed by Li Can, the overall Manager of China’s leading medical and healthcare group. It involved collaboration between China’s SINOPHARMA and NIH, also as proposed the 2 to sign a memorandum of understanding (MoU) so as to conduct Covid-19 vaccine clinical trials on recruited (Pakistani) participants at the power at the NIH. SINOPHARMA is an immunisation research institution under the direct leadership of the State -Owned Assets Supervision and Administration Commission (SASAC) of the State Council. In anticipation that the clinical trials would achieve success , SINOPHARMA promises ‘the subsequent introduction of the vaccine in Pakistan,’ the letter read. The letter also discussed a highly sophisticated clinical experiment, that both the power…